» Articles » PMID: 30905653

Differential Expression of SV2A in Hippocampal Glutamatergic and GABAergic Terminals During Postnatal Development

Overview
Journal Brain Res
Specialty Neurology
Date 2019 Mar 26
PMID 30905653
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The function of synaptic vesicle protein 2A (SV2A) has not been clearly identified, although it has an essential role in normal neurotransmission. Changes in SV2A expression have been linked to several diseases that could implicate an imbalance between excitation and inhibition, such as epilepsy. Although it is known that SV2A expression is necessary for survival, SV2A expression and its relationship with γ-aminobutyric acid (GABA) and glutamate neurotransmitter systems along development has not been addressed. This report follows SV2A expression levels in the rat hippocampus and their association with glutamatergic and GABAergic terminals along postnatal development. Total SV2A expression was assessed by real time PCR and western blot, while immunofluorescence was used to identify SV2A protein in the different hippocampal layers and its co-localization with GABA or glutamate vesicular transporters. SV2A was dynamically regulated along development and its association with GABA or glutamate transporters varied in the different hippocampal layers. In the principal cells layers (granular and pyramidal), SV2A protein was preferentially localized to GABAergic terminals, while in the hilus and stratum lucidum SV2A was associated mainly to glutamatergic terminals. Although SV2A was ubiquitously expressed in the entire hippocampus, it established a differential association with excitatory or inhibitory terminals, which could contribute to the maturation of excitatory/inhibitory balance.

Citing Articles

Control of Synaptotagmin-1 Trafficking by SV2A-Mechanism and Consequences for Presynaptic Function and Dysfunction.

Hogg J, Cousin M J Neurochem. 2025; 169(1):e16308.

PMID: 39853744 PMC: 11758464. DOI: 10.1111/jnc.16308.


Synaptic Vesicle Glycoprotein 2A Knockout in Parvalbumin and Somatostatin Interneurons Drives Seizures in the Postnatal Mouse Brain.

Bartholome O, Neirinckx V, De La Brassinne O, Desloovere J, Van Den Ackerveken P, Raedt R J Neurosci. 2025; 45(8).

PMID: 39753304 PMC: 11841765. DOI: 10.1523/JNEUROSCI.1169-24.2024.


Impact of levetiracetam and ethanol on memory, selected neurotransmitter levels, oxidative stress parameters, and essential elements in rats.

Zwierzynska E, Klimczak M, Nasiadek M, Stragierowicz J, Pietrzak B Pharmacol Rep. 2024; 76(6):1363-1376.

PMID: 39352642 PMC: 11582331. DOI: 10.1007/s43440-024-00659-5.


Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.

Howes O, Marcinkowska J, Turkheimer F, Carr R Neuropsychopharmacology. 2024; 50(1):164-183.

PMID: 39134769 PMC: 11525650. DOI: 10.1038/s41386-024-01943-x.


The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

Uliana D, Lisboa J, Gomes F, Grace A Biochem Pharmacol. 2024; 228:116298.

PMID: 38782077 PMC: 11410545. DOI: 10.1016/j.bcp.2024.116298.